Repair of a wound is orchestrated by signals from numerous growth factor, chemokines, and matrix fragments which are presented in response to wounding. Thus, a major question concerns how the cells integrate the multitude of signals to respond with the location- and time-appropriate behavior. For instance, what controls the major decision point to change from fibroblast repopulation to fibroblast-mediated wound closure? We hypothesize that there are specific intracellular signaling elements that integrate diverse extracellular signals to determine the exact biophysical response. Our goals are to fully define the intracellular pathways which lead from EGFR signaling to enhanced cellular responses critical for repair, movement and contractility to close the wound, and to determine the sites at which regulatory chemokines modulate this signaling to dictate specific cell functions. During the first period of this grant we found that growth factors and ELR-CXC chemokines promoted or limited cell motility, respectively, by affecting cell-substratum adhesiveness, and that this was mediated by activation, or inhibition thereof, of calpain. These studies have uncovered a novel, central role for the intracellular protease calpain in regulating the cellular responses to EGFR activation. Thus, we hypothesize that calpain is such an integrator of extracellular signals controlling the specific biophysical aspects of adhesiveness to alter the overall cell response to its changing environment from one of motility to contraction. To understand the cellular mechanisms to rationally design interventions, we propose to test the following hypotheses that probe the molecular mechanisms by which EGFR signals fibroblast motility and contractility and the mechanism by which these signaling pathways are modulated by wound chemokines: I. That the intracellular protease calpain serves as a central switch between pro- (EGF) and counter-regulatory (IP-10) signals for motility. II. That EGFR-mediated de-adhesion is primarily signaled by plasma membrane-localized activation of erk MAP kinases and calpain. III. That IP-10, by negatively regulating calpain activation and de-adhesion, promotes enhanced EGFR-mediated cell contractility and promotes wound closure. Understanding the delicate balance of these molecular mechanisms is important for rationally designing interventions to achieve normal wound healing.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM054739-07
Application #
6386554
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Ikeda, Richard A
Project Start
1996-07-01
Project End
2004-07-31
Budget Start
2001-08-01
Budget End
2002-07-31
Support Year
7
Fiscal Year
2001
Total Cost
$258,337
Indirect Cost
Name
University of Pittsburgh
Department
Pathology
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Shao, Hanshuang; Yi, Xiao-Ming; Wells, Alan (2008) Epidermal growth factor protects fibroblasts from apoptosis via PI3 kinase and Rac signaling pathways. Wound Repair Regen 16:551-8
Allen, Fred D; Asnes, Clara F; Chang, Philip et al. (2002) Epidermal growth factor induces acute matrix contraction and subsequent calpain-modulated relaxation. Wound Repair Regen 10:67-76
Glading, A; Uberall, F; Keyse, S M et al. (2001) Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem 276:23341-8
Narang, A; Subramanian, K K; Lauffenburger, D A (2001) A mathematical model for chemoattractant gradient sensing based on receptor-regulated membrane phospholipid signaling dynamics. Ann Biomed Eng 29:677-91
Glading, A; Chang, P; Lauffenburger, D A et al. (2000) Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem 275:2390-8
Shiraha, H; Gupta, K; Drabik, K et al. (2000) Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. J Biol Chem 275:19343-51
Shiraha, H; Glading, A; Gupta, K et al. (1999) IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity. J Cell Biol 146:243-54
Qin, H; Moellinger, J D; Wells, A et al. (1998) Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. J Immunol 161:6664-73
Xie, H; Pallero, M A; Gupta, K et al. (1998) EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway. J Cell Sci 111 ( Pt 5):615-24
Hardy, R W; Wickramasinghe, N S; Ke, S C et al. (1997) Fatty acids and breast cancer cell proliferation. Adv Exp Med Biol 422:57-69

Showing the most recent 10 out of 13 publications